The expression of ALDH1A2 was shown to be reduced in cancer tissues compared to that in normal epithelial regions, which was associated with an unfavorable prognosis in prostate and head and neck cancers [13,14]. The gene discussed is ALDH1A2; the disease is head and neck cancer.